• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质组学与泌尿系统疾病临床转化的机遇

Proteomics and opportunities for clinical translation in urological disease.

作者信息

Vaezzadeh Ali R, Steen Hanno, Freeman Michael R, Lee Richard S

机构信息

Department of Urology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

J Urol. 2009 Sep;182(3):835-43. doi: 10.1016/j.juro.2009.05.001. Epub 2009 Jul 17.

DOI:10.1016/j.juro.2009.05.001
PMID:19616261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4370209/
Abstract

PURPOSE

Proteomics is a rapidly growing new discipline that has the potential to increase and improve the understanding of protein function and interaction in the context of systems biology. As a translational science it has the potential to identify many new therapeutic targets as well as diagnostic and prognostic biomarkers of disease. Proteomics approaches consist of a combination of powerful technologies such as protein/peptide separation, identification and bioinformatic detection, and quantitation based on powerful computational data processing tools. We present an overview of current proteomics technologies, a review of proteomics applications in urology and a perspective on the future of proteomics in clinical medicine.

MATERIALS AND METHODS

A literature search was performed on the basic concepts of proteomics and technologies commonly used in this field. Advantages, challenges and limitations of current proteomics approaches are discussed, and proteomics applications in the field of urology are presented.

RESULTS

The proteomics approaches to answer clinical questions have only recently been introduced. Many different technologies have been used in this field, which is moving from simple description to quantitative clinical applications.

CONCLUSIONS

Proteomics offers new approaches to the study of genitourinary tract diseases, and the potential to identify clinically relevant biomarkers and new therapeutic targets.

摘要

目的

蛋白质组学是一门迅速发展的新学科,有潜力在系统生物学背景下增进和改善对蛋白质功能及相互作用的理解。作为一门转化科学,它有潜力识别许多新的治疗靶点以及疾病的诊断和预后生物标志物。蛋白质组学方法由多种强大技术组合而成,如蛋白质/肽分离、鉴定和生物信息学检测,以及基于强大计算数据处理工具的定量分析。我们概述了当前的蛋白质组学技术,回顾了蛋白质组学在泌尿外科的应用,并展望了蛋白质组学在临床医学中的未来。

材料与方法

对蛋白质组学的基本概念以及该领域常用技术进行了文献检索。讨论了当前蛋白质组学方法的优势、挑战和局限性,并介绍了蛋白质组学在泌尿外科领域的应用。

结果

用于回答临床问题的蛋白质组学方法直到最近才被引入。该领域已使用了许多不同技术,正从简单描述向定量临床应用发展。

结论

蛋白质组学为泌尿生殖道疾病的研究提供了新方法,并有潜力识别临床相关生物标志物和新的治疗靶点。

相似文献

1
Proteomics and opportunities for clinical translation in urological disease.蛋白质组学与泌尿系统疾病临床转化的机遇
J Urol. 2009 Sep;182(3):835-43. doi: 10.1016/j.juro.2009.05.001. Epub 2009 Jul 17.
2
Challenges and opportunities for discovery of disease biomarkers using urine proteomics.利用尿液蛋白质组学发现疾病生物标志物面临的挑战与机遇
Pediatr Int. 2011 Feb;53(1):1-6. doi: 10.1111/j.1442-200X.2010.03253.x.
3
Approaching clinical proteomics: current state and future fields of application in cellular proteomics.临床蛋白质组学方法学:细胞蛋白质组学中当前的应用领域和未来的发展方向。
Cytometry A. 2009 Oct;75(10):816-32. doi: 10.1002/cyto.a.20779.
4
Approaching clinical proteomics: current state and future fields of application in fluid proteomics.走近临床蛋白质组学:液体蛋白质组学的现状与未来应用领域
Clin Chem Lab Med. 2009;47(6):724-44. doi: 10.1515/CCLM.2009.167.
5
Proteomics and peptidomics: moving toward precision medicine in urological malignancies.蛋白质组学与肽组学:迈向泌尿生殖系统恶性肿瘤的精准医学
Oncotarget. 2016 Aug 9;7(32):52460-52474. doi: 10.18632/oncotarget.8931.
6
Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.蛋白质组学对心血管健康和疾病的变革性影响:美国心脏协会的科学声明。
Circulation. 2015 Sep 1;132(9):852-72. doi: 10.1161/CIR.0000000000000226. Epub 2015 Jul 20.
7
Urinary exosomes and proteomics.尿外泌体与蛋白质组学。
Mass Spectrom Rev. 2011 Nov-Dec;30(6):1185-202. doi: 10.1002/mas.20319. Epub 2011 May 4.
8
Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases.用于监测膀胱健康和泌尿系统疾病的尿液蛋白质组学和代谢组学研究。
BMC Urol. 2016 Mar 22;16:11. doi: 10.1186/s12894-016-0129-7.
9
Current state of the art for enhancing urine biomarker discovery.增强尿液生物标志物发现的当前技术水平。
Expert Rev Proteomics. 2016 Jun;13(6):609-26. doi: 10.1080/14789450.2016.1190651.
10
Proteomics--a blessing or a curse? Application of proteomics technology to transplant medicine.蛋白质组学——福兮祸兮?蛋白质组学技术在移植医学中的应用。
Transplantation. 2011 Sep 15;92(5):499-509. doi: 10.1097/TP.0b013e3182265358.

引用本文的文献

1
An in-depth comparison of the male pediatric and adult urinary proteomes.男性儿科与成人尿液蛋白质组的深入比较。
Biochim Biophys Acta. 2014 May;1844(5):1044-50. doi: 10.1016/j.bbapap.2013.05.008. Epub 2013 May 22.
2
Adsorption of urinary proteins on the conventionally used urine collection tubes: possible effects on urinary proteome analysis and prevention of the adsorption by polymer coating.传统使用的尿液收集管对尿液蛋白质的吸附:对尿液蛋白质组分析的可能影响以及通过聚合物涂层防止吸附
Int J Proteomics. 2011;2011:502845. doi: 10.1155/2011/502845. Epub 2011 Sep 12.
3
Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin.

本文引用的文献

1
Optimizing sample handling for urinary proteomics.优化尿液蛋白质组学的样本处理
J Proteome Res. 2008 Sep;7(9):4022-30. doi: 10.1021/pr800301h. Epub 2008 Jul 29.
2
Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach.通过无标记定量蛋白质组学方法揭示的癌细胞中的新型基质金属蛋白酶-9底物
Mol Cell Proteomics. 2008 Nov;7(11):2215-28. doi: 10.1074/mcp.M800095-MCP200. Epub 2008 Jul 2.
3
Cryotherapy for prostate cancer: what we know, what we need to know.前列腺癌的冷冻疗法:我们所知道的,我们需要知道的。
卵巢癌患者尿液中排出的 CD59、激肽原-1、α-胰蛋白酶抑制剂重链 H4 片段和白蛋白的水平不同。
Proteome Sci. 2010 Nov 17;8:58. doi: 10.1186/1477-5956-8-58.
4
One-step sample concentration, purification, and albumin depletion method for urinary proteomics.一步法尿液蛋白质组学样品浓缩、纯化和白蛋白去除方法。
J Proteome Res. 2010 Nov 5;9(11):6082-9. doi: 10.1021/pr100924s. Epub 2010 Oct 15.
J Urol. 2008 Aug;180(2):437-8. doi: 10.1016/j.juro.2008.05.081. Epub 2008 Jun 11.
4
Towards standard protocols and guidelines for urine proteomics: a report on the Human Kidney and Urine Proteome Project (HKUPP) symposium and workshop, 6 October 2007, Seoul, Korea and 1 November 2007, San Francisco, CA, USA.
Proteomics. 2008 Jun;8(11):2156-9. doi: 10.1002/pmic.200800138.
5
A multiplexed quantitative strategy for membrane proteomics: opportunities for mining therapeutic targets for autosomal dominant polycystic kidney disease.一种用于膜蛋白质组学的多重定量策略:挖掘常染色体显性多囊肾病治疗靶点的机遇
Mol Cell Proteomics. 2008 Oct;7(10):1983-97. doi: 10.1074/mcp.M800068-MCP200. Epub 2008 May 18.
6
Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE): advances and perspectives.二维聚丙烯酰胺凝胶电泳(2D-PAGE):进展与展望。
Biotechniques. 2008 Apr;44(5):697-8, 700. doi: 10.2144/000112823.
7
Isolation and identification of potential urinary microparticle biomarkers of bladder cancer.膀胱癌潜在尿液微粒生物标志物的分离与鉴定
J Proteome Res. 2008 May;7(5):2088-96. doi: 10.1021/pr700775x. Epub 2008 Mar 29.
8
Integrated analytical strategies for the study of phosphorylation and glycosylation in proteins.蛋白质磷酸化和糖基化研究的综合分析策略。
Mass Spectrom Rev. 2008 May-Jun;27(3):207-36. doi: 10.1002/mas.20164.
9
Temporal variations of the postnatal rat urinary proteome as a reflection of systemic maturation.出生后大鼠尿液蛋白质组的时间变化反映全身成熟情况。
Proteomics. 2008 Mar;8(5):1097-112. doi: 10.1002/pmic.200700701.
10
Hybrid mass spectrometers for tandem mass spectrometry.用于串联质谱分析的混合质谱仪。
J Am Soc Mass Spectrom. 2008 Feb;19(2):161-72. doi: 10.1016/j.jasms.2007.11.013. Epub 2007 Nov 29.